The estimated Net Worth of Jose H Bedoya is at least $1.47 millió dollars as of 8 February 2024. Mr. Bedoya owns over 3,932 units of Surmodics stock worth over $1,181,137 and over the last 21 years he sold SRDX stock worth over $144,174. In addition, he makes $148,000 as Independent Director at Surmodics.
Sign up
Mr. Bedoya SRDX stock SEC Form 4 insiders trading
Jose has made over 10 trades of the Surmodics stock since 2013, according to the Form 4 filled with the SEC. Most recently he exercised 3,932 units of SRDX stock worth $94,171 on 8 February 2024.
The largest trade he's ever made was exercising 11,450 units of Surmodics stock on 21 May 2018 worth over $141,980. On average, Jose trades about 1,280 units every 88 days since 2004. As of 8 February 2024 he still owns at least 30,108 units of Surmodics stock.
You can see the complete history of Mr. Bedoya stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jose Bedoya biography
Jose H. Bedoya serves as Independent Director of the Company. He has been a director of the Company since 2002. Mr. Bedoya served as President and Chief Executive Officer of Otologics, LLC, a Colorado-based technology company he founded in 1996, until 2015. Otologics filed for Chapter 11 bankruptcy protection in July 2012. From 1986 to 1996, Mr. Bedoya held a number of positions at Storz Instrument Company, then a division of American Cyanamid and later a division of American Home Products, including Director of Operations, Director of Research and Director of Commercial Development. Prior to that, he served as Vice President of Research and Development for Bausch & Lomb’s surgical division.
What is the salary of Jose Bedoya?
As the Independent Director of Surmodics, the total compensation of Jose Bedoya at Surmodics is $148,000. There are 15 executives at Surmodics getting paid more, with Gary Maharaj having the highest compensation of $2,343,630.
How old is Jose Bedoya?
Jose Bedoya is 63, he's been the Independent Director of Surmodics since 2002. There are 3 older and 17 younger executives at Surmodics. The oldest executive at Surmodics, Inc. is David Dantzker, 76, who is the Independent Director.
What's Jose Bedoya's mailing address?
Jose's mailing address filed with the SEC is 604 10TH STREET, , BOULDER, CO, 80302.
Insiders trading at Surmodics
Over the last 21 years, insiders at Surmodics have traded over $26,204,565 worth of Surmodics stock and bought 19,725 units worth $436,251 . The most active insiders traders include Jeffrey C Smith, Gary R Maharaj és Value Lp Starboard Value Gp.... On average, Surmodics executives and independent directors trade stock every 34 days with the average trade being worth of $415,014. The most recent stock trade was executed by Joseph J. Stich on 21 August 2024, trading 21,285 units of SRDX stock currently worth $706,662.
What does Surmodics do?
surmodics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. throughout its transformation, surmodics’ mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.
What does Surmodics's logo look like?
Complete history of Mr. Bedoya stock trades at Surmodics
Surmodics executives and stock owners
Surmodics executives and other stock owners filed with the SEC include:
-
Gary Maharaj,
President, Chief Executive Officer, Director -
Gary R. Maharaj,
CEO, Pres & Director -
Teri Sides,
Senior Vice President, Chief Marketing Officer -
Charles Olson,
Senior Vice President of Commercial and Business Development, Medical Devices -
Gregg Sutton,
Vice President - Research and Development, Medical Devices -
Thomas Greaney,
Chief Operating Officer, Medical Devices -
Timothy Arens,
Chief Financial Officer, Vice President - Finance -
Joseph Stich,
Vice President, General Manager - In Vitro Diagnostics -
Gordon S. Weber,
Sr. VP of Legal, Gen. Counsel & Sec. -
Timothy J. Arens,
Sr. VP of Fin. & Information Technology and CFO -
Joseph J. Stich,
Sr. VP and GM of HR & In Vitro Diagnostics -
Teryl L. W. Sides,
Sr. VP of Product Devel. & Chief Marketing Officer -
Susan Knight,
Non-Executive Independent Chairman of the Board -
Ronald Kalich,
Independent Director -
David Dantzker,
Independent Director -
Jose Bedoya,
Independent Director -
Shawn McCormick,
Independent Director -
Lisa Heine,
Independent Director -
Nusrath Sultana,
Vice President - Clinical Affairs -
Gordon Weber,
Senior Vice President - Legal, General Counsel, Secretary -
Gregg S. Sutton,
VP of R&D - Medical Devices -
Charles W. Olson,
Sr. VP of Commercial & Bus. Devel. of Medical Devices -
John D. Manders,
Corp. Controller & Principal Accounting Officer -
Lise W Duran,
VP Product Development -
Andrew D. C. La Frence,
VP of Finance & CFO -
Amy E. Seibert,
Principal Accounting Officer -
Michael J Shoup,
Vice President -
Douglas P Astry,
General Manager -
Aron B Anderson,
VP & Chief Scientific Officer -
John C. Middleton,
VP, Drug Del, Product Dev -
Brian L Robey,
Vice President -
Paul A Lopez,
Vice President -
Bruce Barclay,
President & COO -
John D. Manders,
Corporate Controller -
Steven J Keough,
VP & Chief IP Counsel -
Peter L Ginsberg,
Vice President -
Bryan K Phillips,
SVP, Gen Counsel & Secretary -
Kendrick B Melrose,
Director -
David A Koch,
Director -
Dale R Olseth,
Chairman and CEO -
Loren R Miller,
Vice President and Controller -
David S Wood,
VP & GM - Drug Del. Bus. Unit -
Patrick E Guire,
Senior Vice President -
Gregory T Yung,
VP Sales & Business Developmen -
Ronald F Ofstead,
VP Chemistry Development -
Richard C Carlson,
VP of Strategic Planning -
Jane M Nichols,
Vice President Marketing -
Marie J Versen,
Vice President -
John W Benson,
Director -
Mary K Brainerd,
Director -
Mark A. Lehman,
Treasurer -
Scott R. Ward,
Director -
Gerald B Fischer,
Director -
Timothy S Nelson,
Director -
Robert C Buhrmaster,
Director -
Eugene C. Rusch,
VP, Manufacturing -
Value Lp Starboard Value Gp...,
-
Philip D Ankeny,
Chief Financial Officer -
Jeffrey C Smith,
Director -
John A Meslow,
Director -
Jan M Webster,
Vice President, HR -
Arthur J Tipton,
Vice President -
Kenneth H Keller,
Director